{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:43:48Z","timestamp":1786545828517,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1038\/ajg.2013.335","type":"journal-article","created":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T07:54:57Z","timestamp":1382428497000},"page":"1877-1888","source":"Crossref","is-referenced-by-count":129,"title":["A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED)"],"prefix":"10.14309","volume":"108","author":[{"given":"Walter","family":"Reinisch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Staun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istvan","family":"Altorjay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew V","family":"Thillainayagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Gratzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Nijhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars L","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.MIB.0000196646.64615.db","article-title":"Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients.","volume":"12","author":"Wells","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"R2-14-20210210","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00054725-199709000-00005","article-title":"Diagnosis and treatment of anemia in inflammatory bowel disease.","volume":"3","author":"Schreiber","year":"1997","journal-title":"Inflamm Bowel Dis"},{"key":"R3-14-20210210","first-page":"49","article-title":"Complications of inflammatory bowel disease.","volume":"47","author":"Gasche","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"R4-14-20210210","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/gut.2003.035758","article-title":"Iron, anaemia, and inflammatory bowel diseases.","volume":"53","author":"Gasche","year":"2004","journal-title":"Gut"},{"issue":"Suppl 7A","key":"R6-14-20210210","doi-asserted-by":"crossref","first-page":"44S","DOI":"10.1016\/j.amjmed.2003.12.011","article-title":"Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature.","volume":"116","author":"Wilson","year":"2004","journal-title":"Am J Med"},{"key":"R7-14-20210210","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/00365520310008818-1","article-title":"Treatment of anaemia in inflammatory bowel disease with iron sucrose.","volume":"39","author":"Bodemar","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"R8-14-20210210","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/j.1572-0241.2005.00250.x","article-title":"Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel diseasea randomized, controlled, open-label, multicenter study.","volume":"100","author":"Schroder","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R9-14-20210210","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00005176-200203000-00011","article-title":"Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease.","volume":"34","author":"Mamula","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R10-14-20210210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.MIB.0000191670.04605.e7","article-title":"Impact of chronic conditions on quality of life in patients with inflammatory bowel disease.","volume":"12","author":"Pizzi","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"R11-14-20210210","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.crohns.2012.07.031","article-title":"State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease.","volume":"7","author":"Reinisch","year":"2013","journal-title":"J Crohns Colitis"},{"key":"R12-14-20210210","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1365-2036.2006.03146.x","article-title":"Systematic review: managing anaemia in Crohns disease.","volume":"24","author":"Kulnigg","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R13-14-20210210","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/ibd.20285","article-title":"Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases.","volume":"13","author":"Gasche","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R14-14-20210210","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1080\/00365520902839667","article-title":"Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study.","volume":"44","author":"Lindgren","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"R15-14-20210210","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/ajg.2009.114","article-title":"Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment.","volume":"104","author":"Kulnigg","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R17-14-20210210","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/ibd.20925","article-title":"Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement.","volume":"15","author":"Gisbert","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"R19-14-20210210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S8756-3282(97)00084-7","article-title":"Saccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules.","volume":"21","author":"Sato","year":"1997","journal-title":"Bone"},{"key":"R20-14-20210210","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1507\/endocrj.45.431","article-title":"Saccharated ferric oxide-induced osteomalacia in Japan: iron-induced osteopathy due to nephropathy.","volume":"45","author":"Sato","year":"1998","journal-title":"Endocr J"},{"key":"R21-14-20210210","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1210\/jc.2008-2396","article-title":"FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study.","volume":"94","author":"Schouten","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-14-20210210","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1258\/acb.2008.008151","article-title":"Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia.","volume":"46","author":"Schouten","year":"2009","journal-title":"Ann Clin Biochem"},{"key":"R23-14-20210210","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF01496662","article-title":"Hypophosphatemia induced by intravenous administration of saccharated iron oxide.","volume":"61","author":"Okada","year":"1983","journal-title":"Klin Wochenschr"},{"key":"R24-14-20210210","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/j.1537-2995.2009.02327.x","article-title":"Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.","volume":"49","author":"Van Wyck","year":"2009","journal-title":"Transfusion"},{"key":"R25-14-20210210","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohns-disease activity.","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"R26-14-20210210","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.","volume":"317","author":"Schroeder","year":"1987","journal-title":"N Engl J Med"},{"key":"R27-14-20210210","first-page":"301","article-title":"Intravenous iron-dextran: therapeutic and experimental possibilities.","volume":"100","author":"Ganzoni","year":"1970","journal-title":"Schweiz Med Wochenschr"},{"key":"R29-14-20210210","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0016-5085(89)80080-0","article-title":"A new measure of health status for clinical trials in inflammatory bowel disease.","volume":"96","author":"Guyatt","year":"1989","journal-title":"Gastroenterology"},{"key":"R30-14-20210210","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1572-0241.2007.01744.x","article-title":"A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.","volume":"103","author":"Kulnigg","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R31-14-20210210","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1053\/j.gastro.2011.06.005","article-title":"FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.","volume":"141","author":"Evstatiev","year":"2011","journal-title":"Gastroenterology"},{"key":"R32-14-20210210","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejpb.2011.03.016","article-title":"A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications.","volume":"78","author":"Jahn","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"R34-14-20210210","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/gut.2010.216929","article-title":"Depletion of luminal iron alters the gut microbiota and prevents Crohns disease-like ileitis.","volume":"60","author":"Werner","year":"2011","journal-title":"Gut"},{"key":"R35-14-20210210","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69061.x","article-title":"Strategies for iron supplementation: oral versus intravenous.","volume":"69","author":"Macdougall","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"R36-14-20210210","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/ndt\/16.9.1879","article-title":"A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients.","volume":"16","author":"Johnson","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R38-14-20210210","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tox.2005.07.023","article-title":"Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity.","volume":"216","author":"Szebeni","year":"2005","journal-title":"Toxicology"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2013335.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2013335","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2013335.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201312000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:47:09Z","timestamp":1786542429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201312000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2013.335","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}